Cost analysis of oral antidepressant drugs available in India
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2015, Vol 5, Issue 5
Abstract
Background: Depression is a disorder that disrupts the public health through factors such as its occurrence, distress, ill health, and economic burden. There is a wide variation in the prices of antidepressant drugs marketed in India. Aims and Objective: To find out the price variations in the oral antidepressant drugs available in India either as a single drug or in combination and to evaluate the differences in the cost of various brands of the same oral antidepressant drug by calculating the percentage variation in cost in Indian rupees. Materials and Methods: The cost of a particular drug being manufactured by different companies, in the same strength and dosage forms, was obtained from ‘‘Current Index of Medical Specialties’’ July–October, 2014, and ‘‘Indian Drug Review, 2014;21(4)’’. The difference between the maximum and minimum prices of the same drug and the percentage variation in the prices was calculated. Result: The prices of a total of 25 drugs (21 single and 4 combination preparations) available in 66 different formulations were analyzed. In single drug therapy, among tricyclic antidepressants, reboxetine (2 mg) showed the maximum price variation of 900%. In atypical antidepressants, bupropion hydrochloride (150 mg) showed the maximum price variation of 447.94%. In selective serotonin reuptake inhibitors (SSRIs), paroxetine (37.5 mg) showed the maximum price variation of 1116.66%. In serotonin norepinephrine reuptake inhibitors (SNRIs), Venlafaxine hydrochloride (37.5 mg) showed the maximum price variation of 246.15%. In monoamine oxidase (MAO)-A inhibitors, moclobemide (150 mg) showed the maximum price variation of 246.15%. In combination therapies, chlordiazepoxide with amitriptyline showed the maximum price variation of 227.23%. Conclusion: The average percentage variations of different brands of the same drug manufactured in India is very wide. The management of the marketing drugs should be directed toward maximizing the therapeutic benefits to the community and minimizing the economic burden.
Authors and Affiliations
Abhinay P Paunikar, Kiran A Bhave
Keywords
Related Articles
- EP ID EP118004
- DOI 10.5455/njppp.2015.5.1105201556
- Views 119
- Downloads 0
Natural menopausal age: Correlation with body mass index and various reproductive factors in postmenopausal women
Background: Natural menopause can be defined as cessation of menstruation in which women have experienced 12 consecutive months of amenorrhea that results from loss of ovarian follicular activity. Usually, women attain m...
Study of relationship between anthropometric parameters and heart rate-corrected QT interval (QTc) in normal body mass index Indian males with abdominal obesity
Background: Abdominal obesity is seen with increased prevalence in South Asians even among those who have a body mass index (BMI) <25 kg/m2 . Increasing intra-abdominal deposition of fat is closely associated with prolon...
The effect of mirror therapy on the gait of chronic stroke patients: A randomized controlled trial
Background: Stroke is a leading public health issue around the world. Stroke leads to a sequence of sensory-motor impairments inclusive of muscle weakness, altered selective motor control, spasticity, and proprioceptive...
Assessment of cardiac sympathovagal activity in the patients suffering from ankylosing spondylitis
Background: Ankylosing spondylitis (AS) is an autoimmune disease which leads to the involvement of skeletal, cardiac, nervous tissues, and other systemic diseases. Aims and Objectives: This study was conducted to assess...
Investigating the effects eight weeks of non-continuous aerobic exercise on the levels of angiopoietin2-like protein and interferon beta in rats suffering from coronary artery disease
Background: Reviewing the previous studies reveals that the balance between stimulators and inhibitors of angiogenesis is of a great deal of importance. Among these factors, it can be pointed to the ANGPT2-like protein a...